DNTH
DNTH
NASDAQ · Biotechnology

Dianthus Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$87.53
+0.16 (+0.18%)
As of Jun 24, 1:25 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 21 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -55.6% upside
Low Target $27.89
Average Target $38.82
High Target $53.79
Current Price $87.53
Current
$87.53
Target
$38.82
$27.89 $38.82 avg $53.79
Scenario Analysis
Bear Case
$27.89
-68.1%
Low target
Base Case
$38.82
-55.6%
Avg target
Bull Case
$53.79
+-38.5%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$96.50
-9.3% from high
52-Week Low
$16.64
+426.0% from low
50-Day SMA
$45.37
+92.9% vs SMA
200-Day SMA
$31.95
+174.0% vs SMA
RSI (14)
42.4
Neutral
Target vs 52W High
$38.82
-59.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.6%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +188.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -8.5%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.9%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.0%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.4%